FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
-8.4%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$22.8B
AUM Growth
-$4.41B
(-16%)
Cap. Flow
-$880M
Cap. Flow
% of AUM
-3.87%
Top 10 Holdings %
Top 10 Hldgs %
36.84%
Holding
614
New
135
Increased
158
Reduced
239
Closed
65
Top Buys
| 1 |
NVIDIA
NVDA
|
$198M |
| 2 |
Netflix
NFLX
|
$190M |
| 3 |
Lowe's Companies
LOW
|
$147M |
| 4 |
Starbucks
SBUX
|
$92.4M |
| 5 |
Novartis
NVS
|
$85.4M |
Top Sells
| 1 |
Abbott
ABT
|
$246M |
| 2 |
Microsoft
MSFT
|
$199M |
| 3 |
Dollar Tree
DLTR
|
$152M |
| 4 |
Salesforce
CRM
|
$144M |
| 5 |
Adobe
ADBE
|
$140M |
Sector Composition
| 1 | Technology | 33.16% |
| 2 | Healthcare | 22.78% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Communication Services | 9.78% |
| 5 | Financials | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Valero Energy
VLO
$48.7B
| $340K | ﹤0.01% |
7,485
-173
| -2% | -$7.86K |
|
377
Agilent Technologies
A
$36.5B
| $331K | ﹤0.01% |
4,621
| – | – |
|
|
SILK
378
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $328K | ﹤0.01% |
10,428
+1,195
| +13% | +$37.6K |
|
|
AMRN
379
Amarin Corp
AMRN
$317M
| $320K | ﹤0.01% |
4,000
-250
| -6% | -$20K |
|
|
TLRA
380
DELISTED
Telaria, Inc.
TLRA
| $311K | ﹤0.01% |
51,794
-386,976
| -88% | -$2.32M |
|
381
Levi Strauss
LEVI
$8.79B
| $310K | ﹤0.01% |
24,974
-155,172
| -86% | -$1.93M |
|
382
Rocket Pharmaceuticals
RCKT
$354M
| $307K | ﹤0.01% |
22,000
-4,000
| -15% | -$55.8K |
|
|
HZNP
383
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $296K | ﹤0.01% |
10,000
+7,000
| +233% | +$207K |
|
384
Kohl's
KSS
$1.86B
| $285K | ﹤0.01% |
19,568
-453
| -2% | -$6.6K |
|
385
Etsy
ETSY
$5.36B
| $279K | ﹤0.01% |
7,246
-7,581
| -51% | -$292K |
|
386
Okta
OKTA
$16.1B
| $276K | ﹤0.01% |
2,260
-3,493
| -61% | -$427K |
|
387
Tetra Tech
TTEK
$9.48B
| $264K | ﹤0.01% |
18,690
-9,265
| -33% | -$131K |
|
388
American Express
AXP
$227B
| $257K | ﹤0.01% |
3,000
-1,400
| -32% | -$120K |
|
389
Workday
WDAY
$61.7B
| $257K | ﹤0.01% |
1,973
-378,831
| -99% | -$49.3M |
|
390
Altice USA
ATUS
$1.05B
| $250K | ﹤0.01% |
11,231
-1,436,037
| -99% | -$32M |
|
391
Dow Inc
DOW
$17.4B
| $240K | ﹤0.01% |
8,215
-188
| -2% | -$5.49K |
|
392
Woodward
WWD
$14.6B
| $240K | ﹤0.01% |
4,037
| – | – |
|
393
Arrowhead Research
ARWR
$4.02B
| $230K | ﹤0.01% |
8,000
-6,000
| -43% | -$173K |
|
394
Inovio Pharmaceuticals
INO
$148M
| $223K | ﹤0.01% |
+2,500
| New | +$223K |
|
395
Beyond Air
XAIR
$11.5M
| $200K | ﹤0.01% |
+1,250
| New | +$200K |
|
396
Fulcrum Therapeutics
FULC
$414M
| $194K | ﹤0.01% |
16,281
-31,500
| -66% | -$375K |
|
397
Citigroup
C
$176B
| $191K | ﹤0.01% |
4,531
-455,410
| -99% | -$19.2M |
|
|
PRNB
398
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $178K | ﹤0.01% |
3,000
-1,000
| -25% | -$59.3K |
|
399
Ocular Therapeutix
OCUL
$2.37B
| $173K | ﹤0.01% |
+35,000
| New | +$173K |
|
400
Kodiak Sciences
KOD
$556M
| $167K | ﹤0.01% |
+3,500
| New | +$167K |
|